CPHI Korea 2026
08/2026 – 08/2026
关于公司
- 法定名称: Hunan Kerey Pharmaceutical Co., Ltd.
- 注册国家: China
- 地址: Caixing Rd, Economic Development Zone, Xinshao County, Shaoyang • Hunan
- 成立年份: 2005
描述:
Originally founded in 2005 in Shaoyang City, Hunan Province as Shaoyang Kerey Chemicals, Hunan Kerey Pharmaceutical specializes in developing steroid hormone materials from stigmasterol as a starting material, along with plant-origin cholesterol and cholic acid materials. Listed on the NEEQ in 2015 and inspected by the US FDA in June 2017, the company built a multifunction workshop for CMO business in 2017, operating five modern workshops that follow GMP regulations to meet USP, EP and BP standards, with strong R&D capabilities expanding beyond steroids into other fine chemicals.
业务活动
原料药 (API)
出口商原料药生产商
医药化学品
原料药生产商
生物制药产品
原料药生产商
原研原料药
原料药生产商
销售市场
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
主要产品/服务
- 原料药 (API): Vitamin D3, 17α- Hydroxyprogesterone, 17alpha-hydroxyprogesterone, Guggulsterones
- 医药化学品: 17a -hydroxy progesterone acetate, Finasteride intermediate, 25-Hydroxy-7-Dehydrocholesterol, API & INTERMEDIATES, 17α-Hydroxy progesterone acetate, Dutasteride API and intermediates
- 原研原料药: Progesterone
我们的产品与服务
Proofs
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论